Overview

Fipamezole in Neurogenic Orthostatic Hypotension

Status:
Unknown status

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Fipamezole is effective in the treatment of orthostatic hypotension and related symptoms in multiple system atrophy and Parkinson's disease.

Phase:

Phase 2

Details

Lead Sponsor:

Juvantia Pharma Ltd

Collaborator:

Santhera Pharmaceuticals